The Syngene Advantage: Accelerating Progress Through Integrated Technology Transfer

At Syngene, technology transfer is a seamless, cross-site collaboration, accelerating your journey from concept to commercialization. This video showcases the synergy between our Bangalore (BSEZ) and Mangalore (MSEZ) campuses, driven by robust systems and deep expertise. Our facilities are built for uncompromising quality, proudly GMP certified, 21 CFR compliant, and USFDA approved, ensuring global standards are met at every step. From advanced process and analytical research to meticulous engineering and safety protocols, we emphasize alignment, transparency, and cost-effective execution. Discover how Syngene’s commitment to scalable, economical, and safe processes, supported by our dedicated teams, translates into reliable outcomes. Partner with us for long-term manufacturing and supply solutions, backed by scientific alignment and operational synergy that truly puts science to work for your success.

Author

Latest Blogs

Antibody drug conjugate delivering a cytotoxic payload to a cancer cell via a chemical linker

The rise of ADCs in oncology: how antibody drug conjugate therapies deliver precision

Scientists reviewing records on a tablet, process knowledge management

Tech transfer in CDMOs: avoiding the scale-up trap

Self-amplifying RNA vaccine vials and syringe representing mRNA-based therapeutics

Self-amplifying RNA: the next chapter in mRNA therapeutics

Laboratory glassware with green leaves illustrating green chemistry in pharmaceuticals.

Green chemistry principles for a sustainable future in pharma

Integrated drug discovery scientist analysing digital lab data

Integrated Drug Discovery: why expertise matters

Bispecific antibodies: engineering complexity into simplicity

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details